Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02119442 · ClinicalTrials.gov registry record · NA
Transcatheter Valve Implantation in Patients With Dysfunctional Left and Right Sided Heart Valves
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT02119442 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 90 participants.
The verdict
NCT02119442, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
A growing body of data, suggests that transcatheter valves are effective when implanted in other locations (mitral, aortic, tricuspid) and in high pressure environments. The investigators plan to offer transcatheter valve implantation as an alternative to high risk surgery in patients who require revision of a stenotic or regurgitant valve in the non-pulmonary position (mitral, aortic, tricuspid). This therapy can provide an alternative to patients who may be considered high risk and may not be able to survive a surgical procedure.The use of the devices on this protocol are for medical treatment and are not part of a clinical trial.
Interventions
- DEVICE Transcather Valve Implantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2013-08 |
| Est. Completion | 2018-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02119442
The ClinicalTrials.gov registry entry for NCT02119442 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcather Valve Implantation is the first listed.
NCT02119442 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02119442 about?
NCT02119442 is a clinical study titled "Transcatheter Valve Implantation in Patients With Dysfunctional Left and Right Sided Heart Valves". A growing body of data, suggests that transcatheter valves are effective when implanted in other locations (mitral, aortic, tricuspid) and in high pressure environments. The investigators plan to offer transcatheter valve implantation as an alternative to high risk surgery in patients who require re...
What is the current status of trial NCT02119442?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2013-08. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02119442?
The interventions under investigation include: Transcather Valve Implantation (DEVICE).
Who is sponsoring clinical trial NCT02119442?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.